We examined the expression levels of phospho-JNK and Bcl-xL in xenograft tumor samples from each group to confirm our in vitro findings concerning the associations between JNK activation, Bcl-xL down-regulation and apoptosis induced by combination of cisplatin and MLN4924 treatment. This evidence concerns the gene BCL2L1 and neoplasm.